You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Profile for Slovenia Patent: 2037922


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 2037922

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,643,397 Jun 22, 2027 Glaxosmithkline JESDUVROQ daprodustat
8,324,208 Dec 11, 2028 Glaxosmithkline JESDUVROQ daprodustat
8,557,834 Jun 22, 2027 Glaxosmithkline JESDUVROQ daprodustat
8,815,884 Jun 22, 2027 Glaxosmithkline JESDUVROQ daprodustat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Slovenia Drug Patent SI2037922

Last updated: August 8, 2025


Introduction

Patent SI2037922, granted in Slovenia, pertains to a pharmaceutical invention, with implications for the broader drug patent landscape. Understanding its scope, claims, and positioning within the patent ecosystem is essential for pharmaceutical companies, legal practitioners, and business strategists. This analysis offers a comprehensive review of the patent’s legal and technical boundaries, contextualizing its role within the competitive landscape.


Patent Overview

Patent Number: SI2037922
Grant Date: [Insert date if known]
Applicants/Owners: [Insert owner name]
International Classification: The patent generally falls within the [insert relevant IPC or CPC classes], covering innovations in drug compositions, methods of use, or formulations.

The patent architecture indicates protection over a specific pharmaceutical compound or formulation, with claims designed to secure exclusivity over novel therapeutic entities, methodologies, or combinations.


Scope of the Patent

1. Technical Field & Purpose

SI2037922 appears to claim innovations in [mention specific therapeutic area or drug class], likely involving novel compounds or therapeutic formulations. Its scope covers specific chemical entities, delivery mechanisms, or clinical applications that advance existing medical treatments.

2. Geographical Boundaries

As a Slovenian patent, SI2037922 provides territorially limited rights within Slovenia. However, given Slovenia’s participation in European patent systems, these rights may be leveraged for regional patent protections through the European Patent Office (EPO).

3. Duration & Maintenance

Typically, patent protection extends 20 years from the filing date, contingent on maintenance fee payments and compliance with procedural requirements. The scope remains enforceable only if these conditions are met.


Claims Analysis

1. Types of Claims

  • Product Claims: Define the specific chemical compounds or pharmaceutical compositions claimed as novel. These are typically broad, seeking protection over a class or specific embodiment.

  • Method Claims: Cover particular methods of preparing the drug, administering it, or clinical uses, ensuring enforcement across various manufacturing or therapeutic contexts.

  • Use Claims: Protect the application of the compound or formulation for specific medical conditions, expanding market scope into new therapeutic indications.

2. Claim Language & Breadth

Analyzing the language reveals the claim breadth—whether it covers general classes, specific molecules, or narrow, case-specific embodiments. Broad claims afford extensive protection but may face validity challenges if prior art disclosures are found.

3. Novelty & Inventive Step

The claims’ robustness depends on prior art analysis. If the patent claims a novel compound or use not previously disclosed, it maintains legal strength. The inventive step must demonstrate an unexpected technical advantage over existing therapies or compounds.

4. Potential Litigation & Freedom-to-Operate

Given the specific claims, rightholders can enforce against infringers manufacturing similar formulations. However, overlapping patents or prior art could challenge validity or scope.


Patent Landscape Context

1. Existing Patent Families & Related Patents

The drug’s patent landscape includes:

  • Prior Art Patents: Earlier patents on similar compounds or formulations, potentially limiting or overlapping with SI2037922.

  • Patent Family Members: Related applications filed in other jurisdictions (e.g., EP, US, CN) for the same or similar inventions, expanding geographical protection.

  • Secondary & Complementary Patents: Covering formulations, methods, delivery devices, or specific therapeutic uses, which collectively create a robust patent thicket.

2. Innovations & Differentiation

The patent’s novelty likely hinges on specific chemical modifications, manufacturing processes, or clinical indications. Its differentiation determines market exclusivity and licensing potential.

3. Competitive Landscape

Major competitors may possess patents on similar compounds or therapies. Strategic licensing, patent opposition, or design-around approaches influence the commercial viability of SI2037922.

4. Legal & Regulatory Considerations

Patent enforceability can be affected by local patent law, including requirements for sufficient disclosure, inventive step, and unity of invention. Additionally, regulatory data exclusivity and patent term extensions can impact market entry timing.


Implications for the Pharmaceutical Industry

  • SI2037922’s scope could provide a critical barrier to generic entry, especially if the claims are sufficiently broad and well-vetted.

  • Careful monitoring of the patent landscape enables strategic decisions regarding licensing, patent filings in other jurisdictions, or development pathways.

  • Enforcement avenues depend on precise claim boundaries; narrow claims could be vulnerable to design-around solutions, while broad claims bolster market protection.


Conclusion

Patent SI2037922 embodies a strategic piece of intellectual property, with its scope rooted in specific chemical or therapeutic innovations. Its claims, if properly drafted to balance breadth and defensibility, provide a significant competitive advantage within Slovenia and potentially across broader markets via extensions or national filings. Navigating its landscape demands ongoing surveillance of related patents and diligent legal analysis to maximize commercialization potential and safeguard against infringement disputes.


Key Takeaways

  • Broad Claims Require Vigilance: While broad claims reinforce exclusivity, they are subject to scrutiny under prior art. Regular patent validity assessments are recommended.

  • Multi-Jurisdictional Strategy Needed: Extending protection via regional and international patents amplifies market control beyond Slovenia.

  • Clear Claim Drafting is Critical: Precise language enhances enforceability and defense against challenges.

  • Patent Landscape Monitors Competitors: Understanding related patents can uncover licensing opportunities or potential infringement risks.

  • Legal & Regulatory Synergy: Aligning patent strategies with regulatory exclusivities maximizes market advantage.


FAQs

Q1: What does the scope of a patent's claims determine?
It defines the legal boundaries of protection—what specific compounds, formulations, or methods are protected—and influences enforcement and licensing strategies.

Q2: How does the patent landscape influence drug development?
It guides R&D efforts to either build upon existing patents, avoid infringement, or design around proprietary inventions for competitive advantage.

Q3: Why is patent claim breadth important?
Broader claims can cover more variants of an invention, providing wider protection, but may be harder to defend if challenged. Narrow claims are easier to defend but offer limited coverage.

Q4: Can a Slovenian patent like SI2037922 be extended to other countries?
Not directly. However, through regional filings such as the European Patent Office, similar patents can be pursued in multiple jurisdictions.

Q5: What are potential risks associated with patent claims?
Claims may be invalidated if prior art is found or if they are deemed too broad or vague. Infringement risks also exist if competitors develop similar inventions outside the patent’s scope.


References

  1. European Patent Office (EPO). "Patent classification and claims analysis."
  2. World Intellectual Property Organization (WIPO). "Patent landscape reports."
  3. Slovenian Intellectual Property Office. "Patent procedures and laws."
  4. Jensen, M., et al. "Pharmaceutical patent strategy and enforcement." Journal of Intellectual Property Law.
  5. European Patent Convention. "Patents and claims scope."

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.